A Study of SRSD216 in Patients With Elevated Lipoprotein (a)

Clinical trial NCT07172646 · RECRUITING

Trial details

NCT number: NCT07172646
Sponsor: Sirius Therapeutics Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hyperlipoproteinemia (a)

Start date: 2025-04-07
Primary completion: 2026-05-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.